Story Poster
Texas A&M Football

Texas A&M ranked No. 6 in Associated Press preseason poll

August 15, 2022
10,206

On Monday, the Associated Press released its preseason poll ahead of the 2022 college football season, and Jimbo Fisher’s Texas A&M Aggies came in at No. 6.

The Aggies are among three Southeastern Conference teams inside the top-six, joining No. 1 Alabama and defending national champion Georgia, who comes in at No. 3. A total of six SEC programs are in the initial top-25 as Arkansas (No. 19), Kentucky (No. 20) and Ole Miss (No. 21) also appear in the AP’s preseason rankings. A&M’s Week 3 opponent, Miami comes in at No. 16.

A year ago, the AP ranked Texas A&M as the sixth-best team in the country in its 2021 preseason list, but hampered by injuries at key positions, the Aggies scuffled to an 8-4 record that included a memorable upset of then-top-ranked Alabama at Kyle Field on Oct. 9. A&M finished last season unranked, dropping out of the AP’s final poll after not playing in the Gator Bowl due to COVID-19 issues within the program.

In addition to being ranked sixth by the AP, the Aggies are also ranked No. 7 in the USA Today Coaches Poll. The coaches also ranked the Aggies sixth ahead of the 2021 campaign.

Texas A&M begins the 2022 season on Sept. 3 against Sam Houston at Kyle Field.



Associated Press Preseason Poll

1. Alabama
2. Ohio State
3. Georgia
4. Clemson
5. Notre Dame
6. Texas A&M
7. Utah
8. Michigan
9. Oklahoma
10. Baylor
11. Oregon
12. Oklahoma State
13. NC State
14. Southern California
15. Michigan State
16. Miami
17. Pittsburgh
18. Wisconsin
19. Arkansas
20. Kentucky
21. Ole Miss

22. Wake Forest
23. Cincinnati
24. Houston
25. BYU

Note: Southeastern Conference programs are italicized.

Discussion from...

Texas A&M ranked No. 6 in Associated Press preseason poll

5,780 Views | 1 Replies | Last: 1 mo ago by jigsaw87
jigsaw87
How long do you want to ignore this user?
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.